1. Home
  2. EKSO vs UG Comparison

EKSO vs UG Comparison

Compare EKSO & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ekso Bionics Holdings Inc.

EKSO

Ekso Bionics Holdings Inc.

HOLD

Current Price

$11.56

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.68

Market Cap

30.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
EKSO
UG
Founded
2005
1942
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
30.2M
IPO Year
2012
1995

Fundamental Metrics

Financial Performance
Metric
EKSO
UG
Price
$11.56
$6.68
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.50
N/A
AVG Volume (30 Days)
119.0K
3.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
7.63%
EPS Growth
41.76
N/A
EPS
N/A
0.20
Revenue
N/A
$12,181,971.00
Revenue This Year
$81.23
N/A
Revenue Next Year
$7.29
N/A
P/E Ratio
N/A
$32.75
Revenue Growth
N/A
11.91
52 Week Low
$0.23
$5.58
52 Week High
$13.50
$10.09

Technical Indicators

Market Signals
Indicator
EKSO
UG
Relative Strength Index (RSI) 57.72 46.93
Support Level $9.18 $6.31
Resistance Level $12.99 $6.75
Average True Range (ATR) 0.96 0.15
MACD 0.05 -0.01
Stochastic Oscillator 52.07 40.00

Price Performance

Historical Comparison
EKSO
UG

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: